QurAlis is fighting to conquer ALS and FTD by creating patient-focused therapies.
We are agnostic about drug modalities and are always on the lookout for new partnerships and technologies that will help us conquer ALS. To support our cause, we seek partners that want to follow this path with us together. We are interested in building relationships with institutional and strategic investors, pharmaceutical companies and, above all, families, who have traveled this road before us.
QurAlis has received golden ticket awards from Pfizer and Amgen and is a JnJ JLabs member.